help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on April 12, 2005
Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2004-2526
A more recent version of this article appeared on July 1, 2005
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
90/7/4383    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lora, M. S.
Right arrow Articles by Walvoord, E. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lora, M. S.
Right arrow Articles by Walvoord, E. C.

Submitted on December 23, 2004
Accepted on April 5, 2005

Adrenal Ganglioneuromas in Children with MEN2: A Report of Two Cases

Melissa S. Lora, Steven G. Waguespack, Jeffrey F. Moley, and Emily C. Walvoord*

Department of Pediatrics, Section of Endocrinology and Diabetology, Indiana University School of Medicine, Riley Hospital for Children, Indianapolis, Indiana; Department of Endocrine Neoplasia and Hormonal Disorders, University of Texas M. D. Anderson Cancer Center, Houston, Texas; Department of Surgical Endocrinology and Oncology, Washington University School of Medicine, St. Louis, Missouri

* To whom correspondence should be addressed. E-mail: ewalvoor{at}iupui.edu.

Ganglioneuromas are extremely rare pediatric tumors of neural crest origin that are composed of mature ganglion cells. Pure ganglioneuromas have never been reported in association with multiple endocrine neoplasia type 2 (MEN2) in humans. The MEN2 syndromes are autosomal dominant syndromes caused by gain of function mutations in the RET proto-oncogene. Multiple endocrine neoplasia 2A (MEN2A) is comprised of medullary thyroid carcinoma (MTC), pheochromocytoma, and parathyroid hyperplasia. Multiple endocrine neoplasia 2B (MEN2B) is characterized by MTC, pheochromocytoma, skeletal abnormalities, neural abnormalities of the gastrointestinal tract, and mucosal neuromas. We report two pediatric patients, one with MEN2A and one with MEN2B, who developed isolated adrenal ganglioneuromas without evidence of pheochromocytomas. Interestingly, two mouse models of MEN2B also exhibit adrenal ganglioneuroma formation. We conclude that ganglioneuroma is a rare but not unexpected finding in the MEN 2 syndromes.


Key words: Ganglioneuroma • Multiple Endocrine Neoplasia Type 2 • Pheochromocytoma • Medullary Thyroid Carcinoma • Children







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2005 by The Endocrine Society